NSD1
Basic information
Region (hg38): 5:177131830-177300213
Previous symbols: [ "STO" ]
Links
Phenotypes
GenCC
Source:
- Weaver syndrome (Definitive), mode of inheritance: AD
- Beckwith-Wiedemann syndrome (Definitive), mode of inheritance: AD
- Sotos syndrome 1 (Definitive), mode of inheritance: AD
- Sotos syndrome 1 (Strong), mode of inheritance: AD
- Sotos syndrome 1 (Strong), mode of inheritance: AD
- Sotos syndrome 1 (Definitive), mode of inheritance: AD
- Sotos syndrome (Supportive), mode of inheritance: AD
- Sotos syndrome (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Sotos syndrome 1; Weaver syndrome; Beckwith-Wiedemann syndrome | AD | Cardiovascular; Oncologic; Renal | While only reported in the minority of individuals, individuals are at increased risk of malignancy, and recognition may allow prompt diagnosis and treatment; Surveillance for cardiac and renal complications may also be beneficial in order to allow prompt recognition and management | Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal | 14148233; 4366187; 6324572; 3565472; 2319581; 1552397; 10507738; 10434127; 11146472; 11078573; 11813184; 11896389; 12464997; 12525543; 14517949; 14571271; 14997421; 15125616; 16010674; 15452385; 15362962; 15455365; 15365454; 16170239; 15942875; 15852475; 16222665; 16780628; 16329110; 17825104; 17480008; 17420391; 18304174; 19914434; 20101679; 20420030; 21677402; 21738022; 21834047; 22012791; 21342349; 20301652 |
ClinVar
This is a list of variants' phenotypes submitted to
- Sotos syndrome (278 variants)
- not provided (129 variants)
- Beckwith-Wiedemann syndrome (23 variants)
- Inborn genetic diseases (18 variants)
- Acute myeloid leukemia;Sotos syndrome (3 variants)
- See cases (3 variants)
- NSD1-related disorder (3 variants)
- Neurodevelopmental delay (2 variants)
- not specified (1 variants)
- Neurodevelopmental disorder (1 variants)
- Non-immune hydrops fetalis (1 variants)
- Intellectual disability (1 variants)
- 18 conditions (1 variants)
- Acute myeloid leukemia (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NSD1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 15 | 189 | 16 | 220 | ||
missense | 40 | 92 | 468 | 118 | 33 | 751 |
nonsense | 110 | 14 | 125 | |||
start loss | 0 | |||||
frameshift | 202 | 32 | 239 | |||
inframe indel | 11 | 17 | ||||
splice donor/acceptor (+/-2bp) | 25 | 18 | 45 | |||
splice region | 5 | 1 | 14 | 13 | 33 | |
non coding | 19 | 69 | 52 | 140 | ||
Total | 377 | 161 | 521 | 377 | 101 |
Highest pathogenic variant AF is 0.00000657
Variants in NSD1
This is a list of pathogenic ClinVar variants found in the NSD1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-177133264-CGG-C | Sotos syndrome | Uncertain significance (May 28, 2019) | ||
5-177134112-T-C | Benign (May 01, 2020) | |||
5-177134747-C-T | Likely benign (Dec 21, 2018) | |||
5-177134981-A-G | Likely benign (Jan 13, 2019) | |||
5-177135096-G-A | not specified • NSD1-related disorder • Sotos syndrome | Conflicting classifications of pathogenicity (Jul 15, 2021) | ||
5-177135122-C-A | Sotos syndrome | Uncertain significance (Sep 24, 2021) | ||
5-177135125-C-T | Inborn genetic diseases | Likely benign (Apr 07, 2023) | ||
5-177135129-G-T | Sotos syndrome | Likely benign (Feb 11, 2022) | ||
5-177135132-G-A | Sotos syndrome | Uncertain significance (Aug 26, 2021) | ||
5-177135137-T-C | not specified • Sotos syndrome | Conflicting classifications of pathogenicity (Nov 03, 2021) | ||
5-177135140-C-A | Inborn genetic diseases | Uncertain significance (Jan 10, 2023) | ||
5-177135142-G-C | Likely benign (Sep 17, 2017) | |||
5-177135145-G-C | NSD1-related disorder | Likely benign (Sep 04, 2019) | ||
5-177135159-C-T | Sotos syndrome | Uncertain significance (Jun 21, 2019) | ||
5-177135161-G-T | Sotos syndrome | Uncertain significance (Sep 02, 2021) | ||
5-177135173-G-T | Sotos syndrome | Likely pathogenic (Aug 19, 2023) | ||
5-177135175-C-T | not specified • Inborn genetic diseases • Sotos syndrome • NSD1-related disorder | Conflicting classifications of pathogenicity (Jun 13, 2024) | ||
5-177135180-A-G | Inborn genetic diseases | Likely benign (Sep 20, 2023) | ||
5-177135194-C-G | Sotos syndrome | Likely benign (Jul 30, 2022) | ||
5-177135200-G-A | Sotos syndrome | Uncertain significance (Oct 10, 2022) | ||
5-177135208-T-G | Uncertain significance (Apr 23, 2019) | |||
5-177135211-A-G | Sotos syndrome | Uncertain significance (Feb 08, 2013) | ||
5-177135216-A-G | Sotos syndrome | Uncertain significance (Aug 28, 2021) | ||
5-177135243-C-G | Inborn genetic diseases | Uncertain significance (Feb 03, 2017) | ||
5-177135244-T-C | Sotos syndrome | Likely benign (Sep 14, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NSD1 | protein_coding | protein_coding | ENST00000439151 | 22 | 167191 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 7.31e-15 | 125741 | 0 | 7 | 125748 | 0.0000278 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.41 | 1065 | 1.43e+3 | 0.746 | 0.0000790 | 17650 |
Missense in Polyphen | 179 | 418.12 | 0.42811 | 5206 | ||
Synonymous | 0.0779 | 523 | 525 | 0.996 | 0.0000282 | 5309 |
Loss of Function | 9.31 | 5 | 111 | 0.0452 | 0.00000678 | 1380 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000441 | 0.0000439 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Histone methyltransferase. Preferentially methylates 'Lys-36' of histone H3 and 'Lys-20' of histone H4 (in vitro). Transcriptional intermediary factor capable of both negatively or positively influencing transcription, depending on the cellular context. {ECO:0000269|PubMed:21196496}.;
- Disease
- DISEASE: Beckwith-Wiedemann syndrome (BWS) [MIM:130650]: A disorder characterized by anterior abdominal wall defects including exomphalos (omphalocele), pre- and postnatal overgrowth, and macroglossia. Additional less frequent complications include specific developmental defects and a predisposition to embryonal tumors. {ECO:0000269|PubMed:14997421}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving NSD1 is found in childhood acute myeloid leukemia. Translocation t(5;11)(q35;p15.5) with NUP98.; DISEASE: Note=A chromosomal aberration involving NSD1 is found in an adult form of myelodysplastic syndrome (MDS). Insertion of NUP98 into NSD1 generates a NUP98-NSD1 fusion product. {ECO:0000269|PubMed:15382262}.;
- Pathway
- Lysine degradation - Homo sapiens (human);Histone Modifications;Pathways Affected in Adenoid Cystic Carcinoma;PKMTs methylate histone lysines;Chromatin modifying enzymes;AndrogenReceptor;Lysine metabolism;Chromatin organization
(Consensus)
Recessive Scores
- pRec
- 0.241
Intolerance Scores
- loftool
- 0.00186
- rvis_EVS
- -1.55
- rvis_percentile_EVS
- 3.24
Haploinsufficiency Scores
- pHI
- 0.661
- hipred
- N
- hipred_score
- 0.471
- ghis
- 0.580
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.959
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nsd1
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype;
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;regulation of histone H3-K36 methylation;regulation of transcription, DNA-templated;histone H3-K36 methylation;histone methylation;regulation of peptidyl-serine phosphorylation;histone H4-K20 methylation;positive regulation of transcription, DNA-templated;regulation of RNA polymerase II regulatory region sequence-specific DNA binding
- Cellular component
- chromatin;nucleus;nucleoplasm;chromosome
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;chromatin binding;transcription coregulator activity;transcription corepressor activity;protein binding;zinc ion binding;histone-lysine N-methyltransferase activity;estrogen receptor binding;histone methyltransferase activity (H4-K20 specific);retinoic acid receptor binding;retinoid X receptor binding;thyroid hormone receptor binding;histone methyltransferase activity (H3-K36 specific);androgen receptor binding